PL3564230T3 - Podstawione związki guanidyny - Google Patents

Podstawione związki guanidyny

Info

Publication number
PL3564230T3
PL3564230T3 PL17886109T PL17886109T PL3564230T3 PL 3564230 T3 PL3564230 T3 PL 3564230T3 PL 17886109 T PL17886109 T PL 17886109T PL 17886109 T PL17886109 T PL 17886109T PL 3564230 T3 PL3564230 T3 PL 3564230T3
Authority
PL
Poland
Prior art keywords
guanidine compound
substituted guanidine
substituted
compound
guanidine
Prior art date
Application number
PL17886109T
Other languages
English (en)
Inventor
Ken-Ichi Komori
Akishi NINOMIYA
Shigeru Ushiyama
Masaru Shinohara
Koji Ito
Tetsuo Kawaguchi
Yasunori Tokunaga
Hiroyoshi Kawada
Haruka YAMADA
Yusuke SHIRAISHI
Masahiro Kojima
Masaaki Ito
Tomio Kimura
Original Assignee
Ube Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ube Industries, Ltd. filed Critical Ube Industries, Ltd.
Publication of PL3564230T3 publication Critical patent/PL3564230T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL17886109T 2016-12-28 2017-12-27 Podstawione związki guanidyny PL3564230T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016255567 2016-12-28
EP17886109.2A EP3564230B1 (en) 2016-12-28 2017-12-27 Substituted guanidine compound
PCT/JP2017/046898 WO2018124179A1 (ja) 2016-12-28 2017-12-27 置換グアニジン化合物

Publications (1)

Publication Number Publication Date
PL3564230T3 true PL3564230T3 (pl) 2022-05-09

Family

ID=62709416

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17886109T PL3564230T3 (pl) 2016-12-28 2017-12-27 Podstawione związki guanidyny

Country Status (20)

Country Link
US (2) US11396514B2 (pl)
EP (1) EP3564230B1 (pl)
JP (1) JP7103228B2 (pl)
KR (1) KR102607007B1 (pl)
CN (1) CN110114350B (pl)
AU (1) AU2017385291B2 (pl)
CA (1) CA3048854A1 (pl)
CY (1) CY1125090T1 (pl)
DK (1) DK3564230T3 (pl)
ES (1) ES2909133T3 (pl)
HR (1) HRP20220383T1 (pl)
HU (1) HUE058181T2 (pl)
LT (1) LT3564230T (pl)
MX (1) MX2019007786A (pl)
PL (1) PL3564230T3 (pl)
PT (1) PT3564230T (pl)
RS (1) RS63103B1 (pl)
RU (1) RU2757279C2 (pl)
SI (1) SI3564230T1 (pl)
WO (1) WO2018124179A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112789277B (zh) * 2018-10-22 2022-11-04 广东东阳光药业有限公司 胍类衍生物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005013793D1 (de) * 2004-07-27 2009-05-20 Astellas Pharma Inc Thiazolderivate mit vap-1-hemmender wirkung
TWI490214B (zh) 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為vap-1抑制劑之用途
US8293729B2 (en) 2009-06-24 2012-10-23 Boehringer Ingelheim International Gmbh Compounds, pharmaceutical composition and methods relating thereto
EP2479165B1 (en) 2009-09-16 2017-10-25 Astellas Pharma Inc. Glycine compound
KR101879011B1 (ko) * 2011-03-15 2018-07-16 아스테라스 세이야쿠 가부시키가이샤 구아니딘 화합물
EP3333163A4 (en) 2015-08-06 2019-01-09 UBE Industries, Ltd. SUBSTITUTED GUANIDINE DERIVATIVE

Also Published As

Publication number Publication date
JP7103228B2 (ja) 2022-07-20
RS63103B1 (sr) 2022-04-29
CN110114350B (zh) 2022-03-04
PT3564230T (pt) 2022-05-19
KR102607007B1 (ko) 2023-11-29
MX2019007786A (es) 2019-08-16
CY1125090T1 (el) 2024-02-16
KR20190097251A (ko) 2019-08-20
AU2017385291A1 (en) 2019-07-18
RU2757279C2 (ru) 2021-10-12
EP3564230A4 (en) 2020-06-03
US20220315599A1 (en) 2022-10-06
LT3564230T (lt) 2022-04-11
HUE058181T2 (hu) 2022-07-28
DK3564230T3 (da) 2022-03-28
JPWO2018124179A1 (ja) 2019-10-31
EP3564230A1 (en) 2019-11-06
BR112019012020A2 (pt) 2019-10-29
CA3048854A1 (en) 2018-07-05
RU2019123574A3 (pl) 2021-03-25
BR112019012020A8 (pt) 2023-01-17
US11814393B2 (en) 2023-11-14
ES2909133T3 (es) 2022-05-05
HRP20220383T1 (hr) 2022-05-13
AU2017385291B2 (en) 2021-02-11
EP3564230B1 (en) 2022-02-09
US20190337962A1 (en) 2019-11-07
SI3564230T1 (sl) 2022-05-31
US11396514B2 (en) 2022-07-26
WO2018124179A1 (ja) 2018-07-05
CN110114350A (zh) 2019-08-09
RU2019123574A (ru) 2021-01-29

Similar Documents

Publication Publication Date Title
SG11201802832UA (en) Pyrimidine compound
GB201700814D0 (en) Compounds
ZA201906811B (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
GB201521524D0 (en) Compound
GB2569388B (en) Compound
GB201721178D0 (en) Compound
GB201721172D0 (en) Compound
GB2569389B (en) Compound
IL258952B (en) A pyranodipyridine compound
GB201721179D0 (en) Compound
GB201721180D0 (en) Compound
GB201617103D0 (en) Compound
GB201702221D0 (en) Compounds
SI3630729T1 (sl) Pirimidinska spojina
GB201610497D0 (en) Compound
GB201609083D0 (en) Synthetic compound
GB201709565D0 (en) Compound
GB201612652D0 (en) Novel compound
SI3564230T1 (sl) Substituirane gvanidinske spojine
IL268060B (en) Phenyldifluoromethyl-substituted prolinamide compound
GB201721673D0 (en) Compound
PL3260289T3 (pl) Element kompozytowy
GB201518950D0 (en) Compound
GB201721324D0 (en) Compound
ZA201801098B (en) Tetrahydrooxepinopyridine compound